So far 2024 has been a busy year conference wise for CIRS!
CIRS staff have presented work and/or moderated sessions at several conferences including DIA Europe, RAPS Euro Convergence, DIA China, HTAi and DIA Global.
Take a look at some of the posters we’ve produced recently:
HTA International (HTAi), Seville, Spain
- Navigating HTA Requirements During Development Through Early HTA Scientific Advice: Insights From Companies’ Strategies, Challenges, And Priorities
- Rare Disease Product Approvals: The Changing Regulatory And HTA Landscape Between 2018-2022
DIA Global, San Diego, USA
- Assessing the Use of Risk-Based Approaches in Four Major Agencies – What is the Impact on the Approval of New Medicines?
- The Economic Impact of Reliance on a National Regulatory Authority: a SAHPRA Case Study
- Comparison of Regulatory Performance of WHO Maturity Level 3 National Medicines Regulatory Authorities (NMRAs) in Africa: Identifying Best Practices
- Evaluation of Good Review Practices in Member Agencies of the East African Medicines Regulatory Harmonisation Initiative
- Assessment of the Regulatory Review Process of the Zambia Medicines Regulatory Authority: Opportunities and Challenges
